We succeed because our scientists leveraging deep understanding of diseases, high quality patient data & disruptive science to deliver starting points for innovative drug discovery.
At Evotec, our therapeutic area expertise is shaped by a core belief: the strongest drug discovery begins with a deep understanding of disease biology and the scientists who explore it. Across our global sites, Evotec’s teams combine world-class therapeutic insight with innovative technologies to uncover the mechanisms that trigger and accelerate progression from health to disease - mechanisms that truly matter for patients.
Our proprietary molecular patient databases and integrated multi-omics strategies allow us to analyse diseases from every biological angle, revealing clinically relevant targets, biomarkers, and patient subgroups early in the discovery phase. These data-rich insights connect seamlessly with human-relevant models, high-throughput experimentation, and advanced computational tools including AI/ ML approaches, empowering our scientists to generate more predictive and meaningful outcomes.
Whether supporting a single target or an entire portfolio, Evotec’s scientists remain at the heart of the approach. Their expertise - amplified by powerful platforms - enables and drives more precise, informed, and effective drug discovery.
